Wave Life Sciences (WVE) Net Margin (2016 - 2025)
Historic Net Margin for Wave Life Sciences (WVE) over the last 11 years, with Q2 2025 value amounting to 580.17%.
- Wave Life Sciences' Net Margin fell 4129800.0% to 580.17% in Q2 2025 from the same period last year, while for Sep 2025 it was 682.25%, marking a year-over-year decrease of 4496700.0%. This contributed to the annual value of 89.57% for FY2024, which is 388100.0% down from last year.
- According to the latest figures from Q2 2025, Wave Life Sciences' Net Margin is 580.17%, which was down 4129800.0% from 510.93% recorded in Q1 2025.
- Wave Life Sciences' 5-year Net Margin high stood at 14.78% for Q3 2023, and its period low was 13685.61% during Q3 2022.
- For the 5-year period, Wave Life Sciences' Net Margin averaged around 2375.3%, with its median value being 510.93% (2025).
- In the last 5 years, Wave Life Sciences' Net Margin plummeted by -136685100bps in 2022 and then skyrocketed by 137004000bps in 2023.
- Wave Life Sciences' Net Margin (Quarter) stood at 1970.82% in 2021, then tumbled by -79bps to 3527.76% in 2022, then surged by 98bps to 56.03% in 2023, then tumbled by -198bps to 167.19% in 2024, then crashed by -247bps to 580.17% in 2025.
- Its Net Margin was 580.17% in Q2 2025, compared to 510.93% in Q1 2025 and 167.19% in Q2 2024.